Literature DB >> 12675274

Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension.

Shoji Suzuki1, Sadanori Ohtsuka, Kimito Ishikawa, Iwao Yamaguchi.   

Abstract

We examined the acute effects of a calcium antagonist, nicardipine, on hemodynamics and blood flow in the left anterior descending coronary (LAD), vertebral and renal arteries of essential hypertensive patients who had complained of chest pain and undergone cardiac catheterization. The blood flow velocities of the LAD, vertebral and renal arteries were measured using a Doppler guidewire and the arterial luminal diameters were measured from the arteriograms. The arterial blood flow was calculated by multiplying the blood flow velocity by the obtained vessel diameter. Coronary flow reserve was evaluated by injecting papaverine into the left coronary artery. After the baseline data had been obtained, intravenous infusion of nicardipine was started and the same hemodynamic, blood flow velocity and arterial diameter measurements were repeated. Blood pressure was decreased and cardiac output was increased by nicardipine infusion. There was a correlation between the decrease in systolic blood pressure and the increase in cardiac output (r = 0.71). The blood flow velocity in the LAD, vertebral and renal arteries tended to increase and there was an increase in the arterial luminal diameter. An increase in blood flow and a lowering of vascular resistance were observed for each artery (p < 0.05). During nicardipine infusion, the diastolic blood flow in the LAD artery was improved (p < 0.05); however, the maximal blood flow in the LAD artery induced by papaverine infusion remained unchanged. Therefore, there is evidence that coronary, vertebral and renal blood flows are improved by nicardipine infusion despite the acute blood pressure reduction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675274     DOI: 10.1291/hypres.26.193

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  4 in total

Review 1.  Intravenous nicardipine: its use in the short-term treatment of hypertension and various other indications.

Authors:  Monique P Curran; Dean M Robinson; Gillian M Keating
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review.

Authors:  Lingzhong Meng
Journal:  Br J Anaesth       Date:  2021-08-12       Impact factor: 9.166

3.  Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation.

Authors:  Viktor Yarotskyy; Guofeng Gao; Lei Du; Sindura B Ganapathi; Blaise Z Peterson; Keith S Elmslie
Journal:  J Biol Chem       Date:  2009-11-02       Impact factor: 5.157

Review 4.  Calcium Channel Blockers in Acute Care: The Links and Missing Links Between Hemodynamic Effects and Outcome Evidence.

Authors:  Jin Wang; David L McDonagh; Lingzhong Meng
Journal:  Am J Cardiovasc Drugs       Date:  2021-01       Impact factor: 3.571

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.